Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 1
2012 2
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Subclinical atrial fibrillation and the risk of stroke.
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Healey JS, et al. N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. N Engl J Med. 2012. PMID: 22236222 Free article. Clinical Trial.
A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, Clémenty J, Boulogne E, Daubert JC; TRIP-HF (Triple Resynchronization In Paced Heart Failure Patients) Study Group. Leclercq C, et al. Among authors: boulogne e. J Am Coll Cardiol. 2008 Apr 15;51(15):1455-62. doi: 10.1016/j.jacc.2007.11.074. J Am Coll Cardiol. 2008. PMID: 18402900 Free article. Clinical Trial.
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group. Padeletti L, et al. Among authors: boulogne e. Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7. Am Heart J. 2008. PMID: 18760135 Clinical Trial.
A prospective randomized evaluation of VV delay optimization in CRT-D recipients: echocardiographic observations from the RHYTHM II ICD study.
Boriani G, Biffi M, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Deharo JC, Becker T, Boulogne E, Trappe HJ; Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. Boriani G, et al. Among authors: boulogne e. Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S120-5. doi: 10.1111/j.1540-8159.2008.02267.x. Pacing Clin Electrophysiol. 2009. PMID: 19250074 Clinical Trial.
Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L; MASCOT study group. Schuchert A, et al. Among authors: boulogne e. Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26. Europace. 2013. PMID: 22927665 Clinical Trial.
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, Lozano IF, Ansalone G, Biffi M, Boulogne E, Leclercq C; B-LEFT HF study group. Boriani G, et al. Among authors: boulogne e. Am Heart J. 2010 Jun;159(6):1052-1058.e1. doi: 10.1016/j.ahj.2010.03.008. Am Heart J. 2010. PMID: 20569719 Clinical Trial.